Deutsche Bank analyst Matt O’Connor on Friday downgraded megabank stocks Bank of America Corp. and J.P.Morgan Chase & Co. to hold from buy. Analysts cut the...
Deutsche Bank analyst Matt O’Connor on Friday downgraded megabank stocks Bank of America Corp. BAC and J.P.Morgan Chase & Co. JPM to hold from buy. Analysts cut the price target on Bank of America to $36 a share from $45 a share and trimmed JPMorgan’s price target to $145 from $155. “It’s tempting to get more positive given stocks are already downsharply, inflation seems to be slowing and Fed rate hikes may be coming to an end,” O’Connor said.
Analysts cut the price target on Bank of America to $36 a share from $45 a share and trimmed JPMorgan’s price target to $145 from $155. “It’s tempting to get more positive given stocks are already downsharply, inflation seems to be slowing and Fed rate hikes may be coming to an end,” O’Connor said. “But our gut is that stocks will set new lows and fully price in a U.S. recession suggesting there’s more risk from here.
日本 最新ニュース, 日本 見出し
Similar News:他のニュース ソースから収集した、これに似たニュース記事を読むこともできます。
Deutsche Bank downgrades Bank of America, JPMorgan Chase as fundamentals weakenDeutsche Bank is shifting its perspective on shares of Bank of America and JPMorgan as macro uncertainties loom.
続きを読む »
JPMorgan downgrades Silvergate Capital, says crypto bank's huge withdrawals can hurt stock long termHigher-than-expected deposit withdrawals by customers at Silvergate Capital is ringing the alarm at JPMorgan.
続きを読む »
Bank of America's top 2023 picks include an under-the-radar tech stockInvestors looking for somewhere to park their money in the new year may want to consider these top stock picks from Bank of America.
続きを読む »
Bank of America sees 50% upside in this global fertilizer stock due to a worldwide shortageThe Wall Street bank says the global fertilizer maker commands a 55% profit margin as it is insulated from the rise in natural gas prices.
続きを読む »
Bank of America downgrades Chevron, calls energy stock a 'victim of its own success'The firm warned gains could be limited as oil cools.
続きを読む »
As COVID vaccine and Paxlovid sales decline, analysts want to know what's next for PfizerPfizer is the latest pandemic stock to face questions about its long-term strategy as revenue from its COVID-19 vaccine and antiviral business starts to dry up.
続きを読む »